Cargando…
Ion Mobility Spectrometry–Mass Spectrometry Defines the Oligomeric Intermediates in Amylin Amyloid Formation and the Mode of Action of Inhibitors
[Image: see text] The molecular mechanisms by which different proteins assemble into highly ordered fibrillar deposits and cause disease remain topics of debate. Human amylin (also known as islet amyloid polypeptide/hIAPP) is found in vivo as amyloid deposits in the pancreatic islets of sufferers of...
Autores principales: | Young, Lydia M., Cao, Ping, Raleigh, Daniel P., Ashcroft, Alison E., Radford, Sheena E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical
Society
2013
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3928500/ https://www.ncbi.nlm.nih.gov/pubmed/24372466 http://dx.doi.org/10.1021/ja406831n |
Ejemplares similares
-
Screening and classifying small molecule inhibitors of amyloid formation using ion mobility spectrometry-mass spectrometry
por: Young, Lydia M., et al.
Publicado: (2014) -
Advances in ion mobility spectrometry–mass spectrometry reveal key insights into amyloid assembly()
por: Woods, L.A., et al.
Publicado: (2013) -
Monitoring Copopulated Conformational States During Protein Folding Events Using Electrospray Ionization-Ion Mobility Spectrometry-Mass Spectrometry
por: Smith, David P., et al.
Publicado: (2007) -
Insights into the role of the beta-2 microglobulin D-strand in amyloid propensity revealed by mass spectrometry
por: Leney, Aneika C., et al.
Publicado: (2014) -
Structural mapping of oligomeric intermediates in an amyloid assembly pathway
por: Karamanos, Theodoros K, et al.
Publicado: (2019)